RB

Robert Hugh Bradbury

AA Astrazeneca Ab: 17 patents #31 of 1,971Top 2%
IC ICI: 15 patents #43 of 2,189Top 2%
ZL Zeneca Limited: 7 patents #70 of 867Top 9%
IP Ici Pharma: 2 patents #21 of 35Top 60%
AS Astrazeneca: 1 patents #11 of 66Top 20%
📍 Macclesfield, GB: #2 of 425 inventorsTop 1%
Overall (All Time): #79,326 of 4,157,543Top 2%
40
Patents All Time

Issued Patents All Time

Showing 1–25 of 40 patents

Patent #TitleCo-InventorsDate
11407755 [1,2,4]triazolo[4,3-b]pyridazines for use in the treatment of proliferative diseases Alfred Arthur Rabow, Michael James Waring, James Francis McCabe, Steven Christopher Glossop, Arshed Mahmood +1 more 2022-08-09
10766905 [1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseases Alfred Arthur Rabow, Michael James Waring, James Francis McCabe, Steven Christopher Glossop, Arshed Mahmood +1 more 2020-09-08
10407432 [1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseases Alfred Arthur Rabow, Michael James Waring, James Francis McCabe, Steven Christopher Glossop, Arshed Mahmood +1 more 2019-09-10
10130617 Chemical compounds David Buttar, Christopher De Savi, Craig Samuel Donald, Richard Albert Norman, Alfred Arthur Rabow +6 more 2018-11-20
9944650 [1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseases Alfred Arthur Rabow, Michael James Waring, James Francis McCabe, Steven Christopher Glossop, Arshed Mahmood +1 more 2018-04-17
9616050 Chemical compounds David Buttar, Christopher De Savi, Craig Samuel Donald, Richard Albert Norman, Alfred Arthur Rabow +6 more 2017-04-11
9155727 Chemical compounds David Buttar, Christopher De Savi, Craig Samuel Donald, Richard Albert Norman, Alfred Arthur Rabow +6 more 2015-10-13
8399667 4-anilino quinazoline derivatives as antiproliferative agents Laurent Francois Andre Hennequin, Jason Grant Kettle 2013-03-19
8258140 Chemical compounds—643 Gregory Richard Carr, Alfred Arthur Rabow, Srinivasa Rao Korupoju, Harikrishna Tumma 2012-09-04
8003649 Bicyclic derivatives for use in the treatment of androgen receptor associated conditions-155 Alfred Arthur Rabow, Neil James Hales 2011-08-23
7820683 4-(1H-indazol-5-yl-amino)-quinazoline compounds as erbB receptor tyrosine kinase inhibitors for the treatment of cancer Bernard Christophe Barlaam, Richard Ducray 2010-10-26
7625908 Quinazoline derivatives Laurent Francois Andre Hennequin, Jason Grant Kettle 2009-12-01
7148230 Quinazoline derivatives Jason Grant Kettle, James Francis McCabe, Andrew Turner, Laurent Francois Andre Hennequin 2006-12-12
7067522 2,4,DI (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents Elizabeth Pease, Emma Jane Williams, Stuart Pearson 2006-06-27
6838464 2,4-Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineaoplastic agents Elizabeth Pease, Emma Jane Williams, Stuart Pearson 2005-01-04
6710052 Pyrimidine compounds Elizabeth Pease, Gloria Anne Breault 2004-03-23
6649608 2,4-di(hetero-)arylamino (oxy)-5-substituted pyrimidines as antineoplastic agents Elizabeth Pease, Gloria Anne Breault, Emma Jane Williams, Jeffrey James Morris 2003-11-18
6593326 2,4-diamino pyrimidine compounds having anti-cell proliferative activity Gloria Anne Breault, Philip J Jewbury, Janet Elizabeth Pease 2003-07-15
6258817 Substituted pyrazin-2-yl-sulphonamide (-3-pyridyl) compounds and uses thereof Roger John Butlin, Roger James 2001-07-10
6083951 Aryl-substituted pyrimidine sulphonamide compounds as endothelin antagonists 2000-07-04
6060475 Substituted pyrazin-2-yl-sulphonamide-(3-pyridyl) compounds and uses thereof Roger John Butlin, Roger James 2000-05-09
5866568 Heterocyclic compounds Roger John Butlin, Roger James 1999-02-02
5861401 N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists 1999-01-19
5668137 N-heterocyclic sulfonamides having endothelin receptor activity Paul J. Phillips, Peter Grahame Ballard, Roger James 1997-09-16
5641793 Pyridine compounds which have useful pharmaceutical activity 1997-06-24